|国家科技期刊平台
首页|期刊导航|安徽医科大学学报|全身动态18F-FDG PET/CT Patlak显像定量参数MRFDGmax和SUVmax在大鼠肝炎、肝纤维化及肝硬化阶段的应用价值

全身动态18F-FDG PET/CT Patlak显像定量参数MRFDGmax和SUVmax在大鼠肝炎、肝纤维化及肝硬化阶段的应用价值OACSTPCD

The application value of quantitative parameters MRFDGmax and SUVmax in the stages of hepatitis,liver fibrosis and cirrhosis in rats by whole-body dynamic 18F-FDG PET/CT Patlak imaging

中文摘要英文摘要

目的 通过全身动态18F-FDG PET/CT Patlak显像,探讨定量参数MRFDGmax、SUVmax在大鼠肝炎、肝纤维化及肝硬化阶段的应用价值.方法 将24只SD大鼠随机分为4组,每组6只,分别为正常组、肝炎组、肝纤维化组、肝硬化组.根据实验分组,对各组大鼠进行CC14油溶液复合法诱导;诱导完成分别对各组大鼠进行全身动态18F-FDG PET/CT pat-lak显像.显像完成后,分析各组肝脏的MRFDGmax、SUVmax、CT值;分别提取各组大鼠血清行肝功能指标(AST、ALT和ALP)检测,并对正常组、肝炎组及肝硬化组的大鼠肝脏行HE染色,肝纤维化组行Masson染色;免疫组化法分析各组肝脏中α-平滑肌肌动蛋白(α-SMA)的表达.数据统计分析采用单因素方差分析、两独立样本t检验和Pearson相关分析.结果 MRFDGmax、SUVmax值在正常组、肝炎组、肝纤维化组及肝硬化组之间差异均有统计学意义(F=84.54、38.35,P<0.001).肝纤维化组与肝硬化组之间CT值差异无统计学意义(t=-0.407,P=0.693),其余各组之间比较差异均有统计学意义(F=112.25,P<0.001).与正常组相比,实验组AST、ALT及ALP呈阶段性上升,差异均有统计学意义(F=93.32、64.63、145.03,P<0.001);HE 染色示正常组肝细胞排列整齐,结构完整;肝炎组大量炎性细胞浸润,脂肪变性;肝硬化组假小叶形成;肝纤维化组Masson染色示胶原纤维增生,被膜增厚.免疫组化检测结果显示,肝炎组、肝纤维化组及肝硬化组α-SMA表达增加,呈阶段性上升,差异有统计学意义(F=80.57,P<0.001).相关性分析示SUVmax与MRFDGmax呈正相关(r=0.967,P<0.01).肝炎组、肝纤维化组及肝硬化组α-SMA分别与AST、ALT、ALP呈正相关(r=0.924、0.756、0.934,P<0.01).结论 全身动态18 F-FDG PET/CT Patlak显像通过定量参数MRFDGmax、SUVmax变化,对监测肝炎、肝纤维化和肝硬化阶段具有一定的应用价值.

Objective To investigate the application value of quantitative parameters MRFDGmax and SUVmax in the stages of hepatitis,liver fibrosis and cirrhosis in rats by whole-body dynamic 18 F-FDG PET/CT Patlak imaging.Methods Twenty-four SD rats were randomly divided into four groups of six rats each,which were the normal group,hepatitis group,liver fibrosis group and cirrhosis group.According to the experimental grouping,rats in each group were induced by the CC14 oil solution complex method.Whole-body dynamic 18 F-FDG PET/CT patlak imaging was performed on each group of rats separately at the completion of induction.After the imaging was com-pleted,the MRFDGmax,SUVmax and CT values of the livers of each group were analyzed;subsequently,the serum of rats in each group was extracted for the detection of liver function indexes(AST,ALT and ALP),and HE staining was performed on the livers of rats in the normal,hepatitis and cirrhosis groups,and Masson staining was performed on those in the liver fibrosis group;the α-SMA expression in the liver tissues of each group was analyzed by immu-nohistochemical method.The data were analyzed by one-way ANOVA,two independent samples t-test and Pearson correlation analysis.Results MRFDGmax,SUVmax values were statistically significant differences among normal,hep-atitis,liver fibrosis and cirrhosis groups(F=84.54,38.35,P<0.001).The difference in CT values between liver fibrosis and cirrhosis groups was not statistically significant(t=-0.407,P=0.693),and the difference was statistically significant when compared between the rest of the groups(F=112.25,P<0.001).Compared with the normal group,AST,ALT and ALP of the experimental group showed a staged increase,and the differences were statistically significant(F=93.32,64.63,145.03,P<0.001).HE staining showed that hepatocytes of the normal group were neatly arranged and structurally intact;a large number of inflammatory cells infiltrated the hepa-titis group with steatosis;pseudo lobe formation was observed in the cirrhosis group.Masson staining of the liver fi-brosis group showed collagen fiber proliferation and thickening of the peritoneum.Immunohistochemistry test results showed that α-SMA expression increased in hepatitis group,liver fibrosis group and cirrhosis group,with a staged increase,and the difference was statistically significant(F=80.57,P<0.001).Correlation analysis showed a positive correlation between SUVmax and MRFDGmax(r=0.967,P<0.01).α-SMA was positively correlated with AST,ALT and ALP in the hepatitis,liver fibrosis and cirrhosis groups,respectively(r=0.924,0.756,0.934,P<0.01).Conclusion Whole-body dynamic 18F-FDG PET/CT Patlak imaging has application value in monitoring hepatitis,liver fibrosis and cirrhosis stages through quantitative parameters MRFDGmax and SUVmax changes.

施慧敏;张金洲;王馨;朱干;赵学峰;汪会

安徽医科大学第一附属医院核医学科,合肥 230022

临床医学

全身动态PET/CTPatlakMRFDGmaxSUVmax肝炎肝纤维化肝硬化

whole-body dynamic PET/CTPatlakMRFDGmaxSUVmaxHepatitisliver fibrosiscirrhosis

《安徽医科大学学报》 2024 (002)

正电子淋巴造影监测PD-1抗体联合放射治疗远隔效应对转移淋巴结的协同作用

230-235 / 6

国家自然科学基金(编号:81801736)

10.19405/j.cnki.issn1000-1492.2024.02.008

评论